ALS Dental was created in 2019 by Ansor LLP partners Peter Strafford and Peter Marson. They identified that the dental laboratory industry was on the cusp of transformation with the potential to improve products and solutions for dentists and patients whilst delivering significant growth and value by building a large dental laboratory group.
Dental manufacturing is undergoing a rapid transformation from a fragmented industry of small laboratories staffed by experienced dental technicians manufacturing crowns, bridges, implants and other dental products by hand to a world of digital workflows and large-scale automated production involving intra-oral scanning, 3D printing and robotics. ALS’s goal is to become the UK’s leading and most respected dental laboratory group, positively disrupting the industry and advancing its capability by integrating progressive businesses, advanced technologies and skilled people.
The business is led by CEO Tom Lavery, formerly Managing Director and Chairman of Johnson & Johnson Medical UK & Ireland and Kenny Burns, CFO.
The company is currently expanding to have nationwide UK coverage and also plans to enter the international laboratory market. ALS has grown from a start-up at the end of 2019 through a mixture of acquisition and organic growth in the crown and bridge and orthodontic segments. ALS has a strong pipeline of future acquisitions and new products that will continue to drive the rapid expansion and development of the group.